Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

ProText Mobility, Inc. TXTM OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

ProText Mobility, Inc. (TXTM) is a Biotechnology company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 50/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Net income is $42,379 (loss), growing at +126.9%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $62,413 against $14M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 23.97 (strong liquidity). Debt-to-assets is 0.4%. Total assets: $15M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 100/100 (Pass), Past 25/100 (Fail), Health 67/100 (Partial), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

TXTM SharesGrow Score Overview

55/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TXTM

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
100/100
TXTM: +0%/yr revenue is, +126.9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
TXTM: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet TXTM: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 23.97 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
TXTM: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0004-0.0094
Volume8.85M
Avg Volume (30D)13.8M
Market Cap$13.63M
Beta (1Y)-3.13
Share Statistics
Shares Outstanding$8.79B
IPO Date2003-08-19
Employees1
CEODylon Du Plooy
Financial Highlights & Ratios
EBITDA$-39.21K
Net Income$-42.38K
Operating Income$-39.21K
Total Debt$62.41K
Net Debt$62.41K
Total Assets$15M
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS74371E2046

Price Chart

Track all markets on TradingView
TXTM
ProText Mobility, Inc. ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.01

People Also View

ACOGF
ACOGF
Alpha Cognition Inc.
$5.73
+0.00%
 LVCLF
LVCLF
Living Cell Technologies Limited
$0.01
+0.00%
 SONN
SONN
Sonnet BioTherapeutics Holdings, Inc.
$1.26
-59.35%
 CELZ
CELZ
Creative Medical Technology Holdings, Inc.
$2.29
+5.53%
 MRES
MRES
Institute of Biomedical Research Corp.
$0.00
-16.00%
 HESG
HESG
Health Sciences Group, Inc.
$0.00
+0.00%
 ENZC
ENZC
Enzolytics Inc.
$0.00
-14.29%
 THER
THER
Theralink Technologies, Inc.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message